The latest New York Times Interactive on your place in the line for COVID-19 vaccines at the state level.
Ending the pandemic will require vaccinating everyone in every corner of the globe; it will require robust, adaptive systems that deliver with speed, scale, and equity as supply and demand shift over time.
Ariadne Labs’ Vaccine Delivery team is leveraging years of studying health care delivery systems to support health officials and decision makers with the tools and evidence needed to allocate, distribute, verify, and generate demand for COVID-19 vaccines.
The Vaccine Delivery team was among the first to raise the alarm about the dangers of vaccine nationalism. To assist leaders manage the initial scarcity of COVID-19 vaccines, the Vaccine Delivery team collaborated with the Center for Global Development to build an interactive web tool to generate predictions on the COVID-19 portfolio, in real-time, with up-to-date data.
As the US started to plan for vaccination, the team co-developed the Vaccine Allocation Planner with Surgo Ventures, which has been endorsed by the National Governors Association and has been used by the NYT, WaPo, WSJ, Univision, and others to visualize equitable vaccine delivery.
The Vaccine Delivery team is now working on new COVID-19 vaccine strategies to reach the people and populations not yet vaccinated in the US, including developing an implementation package for primary care providers to engage them in vaccination, aiding state and federal leaders in capturing best practices and figuring out how to track and improve vaccination delivery.
The team serves on the CONVINCE (COVID-19 New Vaccine Information, Communication, and Engagement) coalition to build the communication and demand generation infrastructure that will increase global vaccine confidence, works to inform media, and connects stakeholders around the globe to build bridges for vaccine delivery. The team is leveraging experience analysing best practices in delivery and its work in the US to help other countries learn and prepare for what’s ahead.
WSJ Graphics on vaccine distribution with data provided by Ariadne Labs and Surgo Ventures.
Ariadne Labs worked with Surgo Ventures and the Post to visualize state by state vaccine distribution.
A collaboration with the New York Times and Surgo Foundation using the Vaccine Allocation Planner to calculate the number of people who will need a vaccine in each state and county — and where you might fit in that line.
When COVID-19 vaccines become available in the US, states will need to allocate them to their highest priority populations. The Vaccine Allocation Planner for COVID-19 helps state and county decision prepare for...
The Center for Global Development and Ariadne Labs have teamed up to better understand how long it will take to develop a COVID-19 vaccine and manufacture it at scale.
Anthony McDonnell, Robert Van Exan, Kalipso Chalkidou, Julie Rosenberg, Rebecca Weintraub, and Prashant Yadav Much of the discussion around society’s ability to return to “normality” after the COVID-19 pandemic has...
It’s not often that a volunteer project on COVID-19 catches the attention of a national vaccine expert. But there was something exceptional about the consistently informative visualizations tweeted by Middlebury College...
Dr. Rebecca Weintraub on NPR discussing the variation in access to vaccines state to state.
Dr. Atul Gawande's work referenced in latest opinion piece from Ezra Klein.
In a Q&A, Dr. Rebecca Weintraub discusses America’s vaccination progress and the potential benefits of global vaccination.
Dr. Rebecca Weintraub on states' vaccine guidelines and their impact on front-line essential workers.
Dr. Rebecca Weintraub remarks on the geopolitical implications of the U.S.'s plans for surplus vaccines.
Miami Herald: With Florida requiring doctor’s note for many, pace of COVID vaccination slows in Miami
Dr. Weintraub in the Miami Herald on the importance of an efficient vaccine delivery system.
Dr. Rebecca Weintraub in USA Today on the evolving challenges of vaccine distribution.
Dr. Rebecca Weintraub in the New York Times on the CDC's latest guidance for vaccinated individuals.
Dr. Rebecca Weintraub on a 'new normal' in Maine this year.
Miami Herald: Florida adds red tape for medically vulnerable while COVID vaccines go unused in Miami
Dr. Rebecca Weintraub on the role of a vaccine honor code in vaccine distribution.
Dr. Rebecca Weintraub on the continued importance of COVID-19 testing.
Dr. Rebecca Weintraub on how vaccine distribution plans may prioritize efficiency at the expense of equity.
Dr. Rebecca Weintraub on the importance of maintaining masking, testing and practicing physical distancing.
Dr. Rebecca Weintraub on the differences between state's vaccine distribution plans.
USA Today: A national system to prioritize COVID-19 vaccines has largely failed as states rely on their own systems
Dr. Rebecca Weintraub in USA Today on the need for data-driven, equitable vaccine delivery systems.
Coverage of Ariadne Labs from the 2021 Northeastern University Computation + Journalism Symposium on Feb. 19
Dr. Atul Gawande discusses vaccine availability with Yahoo Finance's Anjalee Khemlani.
Fortune: States are ‘diverging from CDC guidance,’ resulting in an unequal vaccine rollout, experts say
Dr. Rebecca Weintraub in Fortune on vaccine delivery challenges.
PBS NewsHour: Slowing the spread of new COVID strains by changing public attitudes toward vaccinations
Dr. Atul Gawande discusses vaccine distribution, new strains, and ongoing challenges.
Dr. Rebecca Weintraub comments on the Tiberius vaccine algorithm.